# Vivmark Residential: filings

VMRK · NYSE · CIK 906107 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vmrk.md) · [Financials](/companies/vmrk/financials.md) · [Filings](/companies/vmrk/filings.md) · [Insiders](/companies/vmrk/insiders.md)

## Reports and events: 296 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1184, 8-K 204, 144 65, SC 13G/A 60, 10-Q 53, 3 34, DEFA14A 21, 10-K 18, DEF 14A 18, 425 15, UPLOAD 15, 5 13, CORRESP 12, 424B5 11, ARS 11, SC 13G 10, 424B3 9, S-3ASR 8, 3/A 5, 4/A 5, SCHEDULE 13G/A 5, EFFECT 4, 25-NSE 3, 8-K/A 3, S-3 3, S-8 3, 15-12B 2, S-3/A 2, S-8 POS 2, SCHEDULE 13G 2, D 1, FWP 1, NO ACT 1, PX14A6G 1, S-3D 1, S-4 1, S-4/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-17 | 16:53 ET | [8-K](/filings/0001193125-26-394451.md) | 8.01 Other events | 0001193125-26-394451 |
| 2026-09-16 | 17:58 ET | [8-K](/filings/0001193125-26-392188.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-392188 |
| 2026-09-09 | 09:02 ET | [8-K](/filings/0001193125-26-385969.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385969 |
| 2026-08-17 | 16:13 ET | [8-K](/filings/0001193125-26-354068.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-354068 |
| 2026-08-17 | 16:01 ET | [8-K](/filings/0001140361-26-033377.md) | 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-033377 |
| 2026-08-12 | 16:30 ET | [8-K](/filings/0001140361-26-032504.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-032504 |
| 2026-08-06 | 21:32 ET | [8-K](/filings/0001193125-26-336170.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336170 |
| 2026-07-31 | 17:04 ET | [8-K](/filings/0001140361-26-030523.md) | 8.01 Other events | 0001140361-26-030523 |
| 2026-07-31 | 16:15 ET | [8-K](/filings/0001193125-26-328612.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-328612 |
| 2026-07-30 | 16:19 ET | [10-Q](/filings/0001193125-26-326170.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326170 |
| 2026-07-22 | 16:28 ET | [8-K](/filings/0001193125-26-312445.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-312445 |
| 2026-06-22 | 16:48 ET | [8-K](/filings/0001193125-26-277623.md) | 5.07 Shareholder vote results | 0001193125-26-277623 |
| 2026-06-08 | 16:06 ET | [8-K](/filings/0001193125-26-261709.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-261709 |
| 2026-05-21 | 07:11 ET | [8-K](/filings/0001193125-26-233381.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-233381 |
| 2026-04-30 | 16:23 ET | [10-Q](/filings/0001193125-26-197417.md) | Quarterly report, period 2026-03-31 | 0001193125-26-197417 |
| 2026-04-28 | 16:38 ET | [8-K](/filings/0001193125-26-187339.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-187339 |
| 2026-04-15 | 16:37 ET | [8-K](/filings/0001193125-26-157146.md) | 7.01 Regulation FD disclosure | 0001193125-26-157146 |
| 2026-04-14 | 16:44 ET | [DEF 14A](/filings/0001193125-26-155007.md) | Proxy statement, period 2026-04-14 | 0001193125-26-155007 |
| 2026-03-02 | 17:59 ET | [8-K](/filings/0001193125-26-083364.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-083364 |
| 2026-02-13 | 16:20 ET | [10-K](/filings/0001193125-26-051433.md) | Annual report, period 2025-12-31 | 0001193125-26-051433 |
| 2026-02-05 | 16:22 ET | [8-K](/filings/0001193125-26-039455.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-039455 |
| 2025-12-04 | 16:25 ET | [8-K](/filings/0001193125-25-308127.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-308127 |
| 2025-12-01 | 17:03 ET | [8-K](/filings/0001193125-25-304028.md) | 7.01 Regulation FD disclosure | 0001193125-25-304028 |
| 2025-10-30 | 16:21 ET | [10-Q](/filings/0001193125-25-258599.md) | Quarterly report, period 2025-09-30 | 0001193125-25-258599 |
| 2025-10-28 | 16:37 ET | [8-K](/filings/0001193125-25-253637.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-253637 |
| 2025-09-08 | 16:28 ET | [8-K](/filings/0000950170-25-113567.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-113567 |
| 2025-09-02 | 16:19 ET | [8-K](/filings/0000906107-25-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000906107-25-000005 |
| 2025-08-06 | 16:19 ET | [10-Q](/filings/0000950170-25-104090.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104090 |
| 2025-08-04 | 16:23 ET | [8-K](/filings/0000950170-25-102035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102035 |
| 2025-07-24 | 16:18 ET | [8-K](/filings/0000950170-25-098347.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-098347 |
| 2025-07-01 | 16:35 ET | [8-K](/filings/0000950170-25-092280.md) | 5.07 Shareholder vote results | 0000950170-25-092280 |
| 2025-06-30 | 08:52 ET | [8-K](/filings/0000950170-25-091221.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-091221 |
| 2025-05-28 | 08:33 ET | [8-K](/filings/0000950170-25-078083.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-078083 |
| 2025-05-15 | 09:04 ET | [8-K](/filings/0000950170-25-072055.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-072055 |
| 2025-05-02 | 16:38 ET | [8-K](/filings/0000950170-25-062853.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-062853 |
| 2025-04-30 | 16:19 ET | [10-Q](/filings/0000950170-25-061082.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061082 |
| 2025-04-29 | 16:24 ET | [8-K](/filings/0000950170-25-060181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-060181 |
| 2025-04-15 | 16:21 ET | [DEF 14A](/filings/0000950170-25-054259.md) | Proxy statement, period 2025-04-15 | 0000950170-25-054259 |
| 2025-02-25 | 08:07 ET | [8-K](/filings/0000950170-25-026098.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-026098 |
| 2025-02-13 | 16:13 ET | [10-K](/filings/0000950170-25-019894.md) | Annual report, period 2024-12-31 | 0000950170-25-019894 |
| 2025-02-03 | 16:20 ET | [8-K](/filings/0000950170-25-012330.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-012330 |
| 2024-12-18 | 16:05 ET | [8-K](/filings/0001193125-24-281281.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-281281 |
| 2024-11-04 | 16:16 ET | [10-Q](/filings/0000950170-24-120716.md) | Quarterly report, period 2024-09-30 | 0000950170-24-120716 |
| 2024-10-30 | 16:26 ET | [8-K](/filings/0000950170-24-119030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119030 |
| 2024-09-24 | 16:48 ET | [8-K](/filings/0000950170-24-109113.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-24-109113 |
| 2024-09-10 | 16:33 ET | [8-K](/filings/0000950170-24-105173.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-105173 |
| 2024-09-10 | 18:37 ET | [8-K](/filings/0000950170-24-104849.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-104849 |
| 2024-09-04 | 16:18 ET | [8-K](/filings/0000950170-24-103414.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-103414 |
| 2024-08-07 | 09:05 ET | [8-K](/filings/0000950170-24-092317.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-092317 |
| 2024-08-01 | 16:15 ET | [10-Q](/filings/0000950170-24-089300.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089300 |

Page 1 of 6. [Older](/companies/vmrk/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.